Besides diabetes and high blood pressure, the following additional health conditions may also contribute to CKD 1 : Cardiovascular disease Systemic or kidney infections Immune system conditions (eg, lupus) Inflammation of the glomeruli (tiny filters) in the kidneys Inherited kidney disease (eg, polycystic kidney disease) Congenital defects (eg, kidney malformation, urinary tract obstruction) Medications and toxins (eg, prolonged medication, chemical, or street drug exposure) Factors such as those described above and various others can contribute to the decline in kidney function characteristic of CKD
The areas of scientific interest include: Nitric oxide signaling Angiogenesis-related pathways Growth-factor communication Gastrointestinal biology Tendon fibroblast models Peptide stability One reason BPC-157 continues to attract scientific interest is that published literature has linked it to multiple biological signaling pathways as opposed to a single molecular target
Abbreviations : NET, norepinephrine transporter
Recommendations Pure Encapsulations recommends between 600-1800 mg per day, in divided doses, between meals
